Persistent reduction of CD4/CD8 lymphocyte ratio amd cell activation before the onset of Type 1 (insulin-dependent) diabetes View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1989-05

AUTHORS

L. Al-Sakkaf, P. Pozzilli, A. C. Tarn, G. Schwarz, E. A. M. Gale, G. F. Bottazzo

ABSTRACT

Over a period of 5 years, lymphocyte subpopulations and their markers of activation were studied prospectively in 56 first degree relatives of Type 1 (insulin-dependent) diabetic probands. Lymphocytes were phenotyped using a panel of monoclonal antibodies which recognise CD3, CD4, CD8 lymphocytes, K/NK cells, HLA Class II products and IL-2 receptors (IL-2r). Twenty-six subjects were negative for islet cell antibody (ICA), 18 had complement fixing ICA (CF-ICA) and 12 only conventional ICA (ICA-IgG). The total number of observations (blood samples collected) was 386. Overall, changes in T cell data were observed in the three groups of first degree relatives compared to 70 normal subjects without a family history of diabetes. Six individuals developed Type 1 diabetes in the course of the study. They all possessed CF-ICA and five out of six showed a persistent reduction (less than 1.5) of the CD4/CD8 lymphocyte ratio before the clinical onset of the disease. Activated lymphocytes were found on two occasions in two of these subjects. We conclude that imbalance of lymphocyte immunoregulatory subsets is present before the onset of Type 1 diabetes in susceptible individuals; the persistence of a reduced CD4/CD8 lymphocyte ratio may reflect the ongoing process leading to B-cell destruction. More... »

PAGES

322-325

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/bf00265550

DOI

http://dx.doi.org/10.1007/bf00265550

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1030608473

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/2502462


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antigens, Differentiation, T-Lymphocyte", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "CD8 Antigens", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetes Mellitus, Type 1", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphocyte Activation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Phenotype", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prediabetic State", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "T-Lymphocytes", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "St Bartholomew's Hospital", 
          "id": "https://www.grid.ac/institutes/grid.416353.6", 
          "name": [
            "Department of Diabetes and Immunogenetics, St. Bartholomew's Hospital, UK", 
            "St. Martins Hospitals, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Al-Sakkaf", 
        "givenName": "L.", 
        "id": "sg:person.0676130551.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0676130551.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Sapienza University of Rome", 
          "id": "https://www.grid.ac/institutes/grid.7841.a", 
          "name": [
            "Department of Diabetes and Immunogenetics, St. Bartholomew's Hospital, UK", 
            "Cattedra di Endocrinologia, University of Rome, La Sapienza, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pozzilli", 
        "givenName": "P.", 
        "id": "sg:person.0576452551.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0576452551.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "St Bartholomew's Hospital", 
          "id": "https://www.grid.ac/institutes/grid.416353.6", 
          "name": [
            "Department of Diabetes and Immunogenetics, St. Bartholomew's Hospital, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tarn", 
        "givenName": "A. C.", 
        "id": "sg:person.0744243751.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0744243751.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "St Bartholomew's Hospital", 
          "id": "https://www.grid.ac/institutes/grid.416353.6", 
          "name": [
            "Department of Diabetes and Immunogenetics, St. Bartholomew's Hospital, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schwarz", 
        "givenName": "G.", 
        "id": "sg:person.010353225202.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010353225202.97"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "St Bartholomew's Hospital", 
          "id": "https://www.grid.ac/institutes/grid.416353.6", 
          "name": [
            "Department of Diabetes and Immunogenetics, St. Bartholomew's Hospital, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gale", 
        "givenName": "E. A. M.", 
        "id": "sg:person.012062434302.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012062434302.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Warwick", 
          "id": "https://www.grid.ac/institutes/grid.7372.1", 
          "name": [
            "Department of Diabetes and Immunogenetics, St. Bartholomew's Hospital, UK", 
            "Department of Immunology, The University College and Middlesex School of Medicine, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bottazzo", 
        "givenName": "G. F.", 
        "id": "sg:person.0723572726.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0723572726.20"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf00275749", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002687211", 
          "https://doi.org/10.1007/bf00275749"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00275749", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002687211", 
          "https://doi.org/10.1007/bf00275749"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00275749", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002687211", 
          "https://doi.org/10.1007/bf00275749"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00275670", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008198878", 
          "https://doi.org/10.1007/bf00275670"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00275670", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008198878", 
          "https://doi.org/10.1007/bf00275670"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00275670", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008198878", 
          "https://doi.org/10.1007/bf00275670"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00274217", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015008654", 
          "https://doi.org/10.1007/bf00274217"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00274217", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015008654", 
          "https://doi.org/10.1007/bf00274217"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00274217", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015008654", 
          "https://doi.org/10.1007/bf00274217"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0092-8674(80)90072-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022873164"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diab.32.1.91", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023059950"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.294.6568.342", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034219379"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diab.33.4.319", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1070734529"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diab.35.12.1416", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1070734960"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078813515", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1989-05", 
    "datePublishedReg": "1989-05-01", 
    "description": "Over a period of 5 years, lymphocyte subpopulations and their markers of activation were studied prospectively in 56 first degree relatives of Type 1 (insulin-dependent) diabetic probands. Lymphocytes were phenotyped using a panel of monoclonal antibodies which recognise CD3, CD4, CD8 lymphocytes, K/NK cells, HLA Class II products and IL-2 receptors (IL-2r). Twenty-six subjects were negative for islet cell antibody (ICA), 18 had complement fixing ICA (CF-ICA) and 12 only conventional ICA (ICA-IgG). The total number of observations (blood samples collected) was 386. Overall, changes in T cell data were observed in the three groups of first degree relatives compared to 70 normal subjects without a family history of diabetes. Six individuals developed Type 1 diabetes in the course of the study. They all possessed CF-ICA and five out of six showed a persistent reduction (less than 1.5) of the CD4/CD8 lymphocyte ratio before the clinical onset of the disease. Activated lymphocytes were found on two occasions in two of these subjects. We conclude that imbalance of lymphocyte immunoregulatory subsets is present before the onset of Type 1 diabetes in susceptible individuals; the persistence of a reduced CD4/CD8 lymphocyte ratio may reflect the ongoing process leading to B-cell destruction.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/bf00265550", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1001482", 
        "issn": [
          "0012-186X", 
          "1432-0428"
        ], 
        "name": "Diabetologia", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "32"
      }
    ], 
    "name": "Persistent reduction of CD4/CD8 lymphocyte ratio amd cell activation before the onset of Type 1 (insulin-dependent) diabetes", 
    "pagination": "322-325", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "91d0873a91bfa9abf8e7329177b7a7d653085251075fe55c30f6d05753393e5a"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "2502462"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0006777"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/bf00265550"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1030608473"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/bf00265550", 
      "https://app.dimensions.ai/details/publication/pub.1030608473"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T13:50", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000371_0000000371/records_130797_00000002.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2FBF00265550"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf00265550'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf00265550'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf00265550'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf00265550'


 

This table displays all metadata directly associated to this object as RDF triples.

182 TRIPLES      21 PREDICATES      48 URIs      31 LITERALS      19 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/bf00265550 schema:about N0134cb63553f4d73bc879df318a015b3
2 N0da6269c8ebb40be97c8ac27ed64b845
3 N42135170de664d4e877c754004dfd7c1
4 N43348ffa8c1748da84c279b430a7bf73
5 N834596320c3346f5ae319efaee78f9e7
6 N8d80644aba964c63987432a75c65dada
7 Nc9454ffe55ac4d18a0399fa7333b84ed
8 Nd760dc1da11747a8927b14446db61583
9 Nd93c01a5a52a40608fa8d683574f7044
10 Ndc7e09cc8ce944efac24ac7d4f4c70fb
11 anzsrc-for:11
12 anzsrc-for:1107
13 schema:author N6f49245ea05f416bab4545001d604244
14 schema:citation sg:pub.10.1007/bf00274217
15 sg:pub.10.1007/bf00275670
16 sg:pub.10.1007/bf00275749
17 https://app.dimensions.ai/details/publication/pub.1078813515
18 https://doi.org/10.1016/0092-8674(80)90072-0
19 https://doi.org/10.1136/bmj.294.6568.342
20 https://doi.org/10.2337/diab.32.1.91
21 https://doi.org/10.2337/diab.33.4.319
22 https://doi.org/10.2337/diab.35.12.1416
23 schema:datePublished 1989-05
24 schema:datePublishedReg 1989-05-01
25 schema:description Over a period of 5 years, lymphocyte subpopulations and their markers of activation were studied prospectively in 56 first degree relatives of Type 1 (insulin-dependent) diabetic probands. Lymphocytes were phenotyped using a panel of monoclonal antibodies which recognise CD3, CD4, CD8 lymphocytes, K/NK cells, HLA Class II products and IL-2 receptors (IL-2r). Twenty-six subjects were negative for islet cell antibody (ICA), 18 had complement fixing ICA (CF-ICA) and 12 only conventional ICA (ICA-IgG). The total number of observations (blood samples collected) was 386. Overall, changes in T cell data were observed in the three groups of first degree relatives compared to 70 normal subjects without a family history of diabetes. Six individuals developed Type 1 diabetes in the course of the study. They all possessed CF-ICA and five out of six showed a persistent reduction (less than 1.5) of the CD4/CD8 lymphocyte ratio before the clinical onset of the disease. Activated lymphocytes were found on two occasions in two of these subjects. We conclude that imbalance of lymphocyte immunoregulatory subsets is present before the onset of Type 1 diabetes in susceptible individuals; the persistence of a reduced CD4/CD8 lymphocyte ratio may reflect the ongoing process leading to B-cell destruction.
26 schema:genre research_article
27 schema:inLanguage en
28 schema:isAccessibleForFree false
29 schema:isPartOf Nb5f3dba299514f308382670961f64543
30 Nfe01805cd63c48b69e724523e6a7efab
31 sg:journal.1001482
32 schema:name Persistent reduction of CD4/CD8 lymphocyte ratio amd cell activation before the onset of Type 1 (insulin-dependent) diabetes
33 schema:pagination 322-325
34 schema:productId N24d354c49b144b069f551fe15d54d3ef
35 N35785b81c26b4b8da4f9afb2c042eec4
36 N9f38316163aa4dc8b4db6c8d36bf3ece
37 Nabd53968edc0429aaf42ab2bc2f102f7
38 Nf59ecbe4f20143e7bfac9bd21ba973a4
39 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030608473
40 https://doi.org/10.1007/bf00265550
41 schema:sdDatePublished 2019-04-11T13:50
42 schema:sdLicense https://scigraph.springernature.com/explorer/license/
43 schema:sdPublisher N7dc8eb06f4b04ca995f8c3fecd5ab885
44 schema:url https://link.springer.com/10.1007%2FBF00265550
45 sgo:license sg:explorer/license/
46 sgo:sdDataset articles
47 rdf:type schema:ScholarlyArticle
48 N0134cb63553f4d73bc879df318a015b3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
49 schema:name Follow-Up Studies
50 rdf:type schema:DefinedTerm
51 N0da6269c8ebb40be97c8ac27ed64b845 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
52 schema:name Humans
53 rdf:type schema:DefinedTerm
54 N23d3b02d94af4ca8aed569d8cd5cb8f1 rdf:first sg:person.012062434302.19
55 rdf:rest Nf92ed54e64b64552b4db9c58f9307acd
56 N24d354c49b144b069f551fe15d54d3ef schema:name dimensions_id
57 schema:value pub.1030608473
58 rdf:type schema:PropertyValue
59 N35785b81c26b4b8da4f9afb2c042eec4 schema:name readcube_id
60 schema:value 91d0873a91bfa9abf8e7329177b7a7d653085251075fe55c30f6d05753393e5a
61 rdf:type schema:PropertyValue
62 N42135170de664d4e877c754004dfd7c1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
63 schema:name Diabetes Mellitus, Type 1
64 rdf:type schema:DefinedTerm
65 N43348ffa8c1748da84c279b430a7bf73 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
66 schema:name T-Lymphocytes
67 rdf:type schema:DefinedTerm
68 N6551cc3fdbd04028858adc238b235bcc rdf:first sg:person.010353225202.97
69 rdf:rest N23d3b02d94af4ca8aed569d8cd5cb8f1
70 N6f49245ea05f416bab4545001d604244 rdf:first sg:person.0676130551.32
71 rdf:rest Ne53444a06cf0468f800425e3871c27ff
72 N7dc8eb06f4b04ca995f8c3fecd5ab885 schema:name Springer Nature - SN SciGraph project
73 rdf:type schema:Organization
74 N7edd2974127c4c9fa60a8213c8eeccd4 rdf:first sg:person.0744243751.78
75 rdf:rest N6551cc3fdbd04028858adc238b235bcc
76 N834596320c3346f5ae319efaee78f9e7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
77 schema:name Prospective Studies
78 rdf:type schema:DefinedTerm
79 N8d80644aba964c63987432a75c65dada schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
80 schema:name Lymphocyte Activation
81 rdf:type schema:DefinedTerm
82 N9f38316163aa4dc8b4db6c8d36bf3ece schema:name doi
83 schema:value 10.1007/bf00265550
84 rdf:type schema:PropertyValue
85 Nabd53968edc0429aaf42ab2bc2f102f7 schema:name nlm_unique_id
86 schema:value 0006777
87 rdf:type schema:PropertyValue
88 Nb5f3dba299514f308382670961f64543 schema:issueNumber 5
89 rdf:type schema:PublicationIssue
90 Nc9454ffe55ac4d18a0399fa7333b84ed schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Phenotype
92 rdf:type schema:DefinedTerm
93 Nd760dc1da11747a8927b14446db61583 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name CD8 Antigens
95 rdf:type schema:DefinedTerm
96 Nd93c01a5a52a40608fa8d683574f7044 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Antigens, Differentiation, T-Lymphocyte
98 rdf:type schema:DefinedTerm
99 Ndc7e09cc8ce944efac24ac7d4f4c70fb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Prediabetic State
101 rdf:type schema:DefinedTerm
102 Ne53444a06cf0468f800425e3871c27ff rdf:first sg:person.0576452551.25
103 rdf:rest N7edd2974127c4c9fa60a8213c8eeccd4
104 Nf59ecbe4f20143e7bfac9bd21ba973a4 schema:name pubmed_id
105 schema:value 2502462
106 rdf:type schema:PropertyValue
107 Nf92ed54e64b64552b4db9c58f9307acd rdf:first sg:person.0723572726.20
108 rdf:rest rdf:nil
109 Nfe01805cd63c48b69e724523e6a7efab schema:volumeNumber 32
110 rdf:type schema:PublicationVolume
111 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
112 schema:name Medical and Health Sciences
113 rdf:type schema:DefinedTerm
114 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
115 schema:name Immunology
116 rdf:type schema:DefinedTerm
117 sg:journal.1001482 schema:issn 0012-186X
118 1432-0428
119 schema:name Diabetologia
120 rdf:type schema:Periodical
121 sg:person.010353225202.97 schema:affiliation https://www.grid.ac/institutes/grid.416353.6
122 schema:familyName Schwarz
123 schema:givenName G.
124 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010353225202.97
125 rdf:type schema:Person
126 sg:person.012062434302.19 schema:affiliation https://www.grid.ac/institutes/grid.416353.6
127 schema:familyName Gale
128 schema:givenName E. A. M.
129 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012062434302.19
130 rdf:type schema:Person
131 sg:person.0576452551.25 schema:affiliation https://www.grid.ac/institutes/grid.7841.a
132 schema:familyName Pozzilli
133 schema:givenName P.
134 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0576452551.25
135 rdf:type schema:Person
136 sg:person.0676130551.32 schema:affiliation https://www.grid.ac/institutes/grid.416353.6
137 schema:familyName Al-Sakkaf
138 schema:givenName L.
139 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0676130551.32
140 rdf:type schema:Person
141 sg:person.0723572726.20 schema:affiliation https://www.grid.ac/institutes/grid.7372.1
142 schema:familyName Bottazzo
143 schema:givenName G. F.
144 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0723572726.20
145 rdf:type schema:Person
146 sg:person.0744243751.78 schema:affiliation https://www.grid.ac/institutes/grid.416353.6
147 schema:familyName Tarn
148 schema:givenName A. C.
149 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0744243751.78
150 rdf:type schema:Person
151 sg:pub.10.1007/bf00274217 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015008654
152 https://doi.org/10.1007/bf00274217
153 rdf:type schema:CreativeWork
154 sg:pub.10.1007/bf00275670 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008198878
155 https://doi.org/10.1007/bf00275670
156 rdf:type schema:CreativeWork
157 sg:pub.10.1007/bf00275749 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002687211
158 https://doi.org/10.1007/bf00275749
159 rdf:type schema:CreativeWork
160 https://app.dimensions.ai/details/publication/pub.1078813515 schema:CreativeWork
161 https://doi.org/10.1016/0092-8674(80)90072-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022873164
162 rdf:type schema:CreativeWork
163 https://doi.org/10.1136/bmj.294.6568.342 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034219379
164 rdf:type schema:CreativeWork
165 https://doi.org/10.2337/diab.32.1.91 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023059950
166 rdf:type schema:CreativeWork
167 https://doi.org/10.2337/diab.33.4.319 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070734529
168 rdf:type schema:CreativeWork
169 https://doi.org/10.2337/diab.35.12.1416 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070734960
170 rdf:type schema:CreativeWork
171 https://www.grid.ac/institutes/grid.416353.6 schema:alternateName St Bartholomew's Hospital
172 schema:name Department of Diabetes and Immunogenetics, St. Bartholomew's Hospital, UK
173 St. Martins Hospitals, London, UK
174 rdf:type schema:Organization
175 https://www.grid.ac/institutes/grid.7372.1 schema:alternateName University of Warwick
176 schema:name Department of Diabetes and Immunogenetics, St. Bartholomew's Hospital, UK
177 Department of Immunology, The University College and Middlesex School of Medicine, UK
178 rdf:type schema:Organization
179 https://www.grid.ac/institutes/grid.7841.a schema:alternateName Sapienza University of Rome
180 schema:name Cattedra di Endocrinologia, University of Rome, La Sapienza, Italy
181 Department of Diabetes and Immunogenetics, St. Bartholomew's Hospital, UK
182 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...